Macloras Tablets

    Macloras Tablets

    S4


    1. What MACLORAS TABLETS is and what it is used for.

    MACLORAS TABLETS is indicated for the treatment of idiopathic Parkinson's disease (PD) as monotherapy (without levodopa) or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.

    2. What you need to know before you take/use MACLORAS TABLETS.

    Contraindications

    MACLORAS TABLETS is contraindicated:

    • in patients with a history of hypersensitivity to the active substance rasagiline or to any of the excipients listed in 6.1.
    • Concomitant treatment with other monoamine oxidase (MAO) inhibitors (including medicines and natural products without prescription e.g. St. John's Wort) or pethidine (see section 4.5). At least 14 days must elapse between discontinuation of rasagiline and initiation of treatment with MAO inhibitors or pethidine.
    • Moderate to severe hepatic impairment.

    Special warnings and precautions for use

    The concomitant use of MACLORAS TABLETS and fluoxetine or fluvoxamine should be avoided (see section 4.5). At least five weeks should elapse between discontinuation of fluoxetine and initiation of treatment with MACLORAS TABLETS. At least 14 days should elapse between discontinuation of MACLORAS TABLETS and initiation of treatment with fluoxetine or fluvoxamine.

    3. How to take/use MACLORAS TABLETS.

    MACLORAS TABLETS is administered orally, at a dose of 1 mg once daily with or without levodopa. May be taken with or without food.

    4. Possible side effects.

    Summary of the safety profile

    In clinical studies in Parkinson's disease patients the frequently reported adverse reactions were: headache, depression, vertigo, and flu (influenza and rhinitis) in monotherapy; dyskinesia, orthostatic hypotension, fall, abdominal pain, nausea and vomiting, and dry mouth in adjunct to levodopa therapy; musculoskeletal pain, as back and neck pain, and arthralgia in both regimens.

    Tabulated summary of adverse reactions

    Monotherapy:

    • System organ class: Frequent: Influenza
    • Neoplasms, benign, malignant and unspecified (including cysts and polyps): Skin carcinoma

    5. How to store MACLORAS TABLETS.

    Special precautions for storage

    Store at or below 25 °C. Protect from moisture. Keep the blisters in the carton until required for use. Do not store in a refrigerator.

    Important Disclaimer

    The Macloras Tablets professional information leaflet below is the property of Macleods Pharmaceuticals Sa and is provided on Somayeza exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Somayeza serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Unlock Exclusive Features

    To ensure the fastest, most secure experience, this feature is exclusively available on the free Somayeza mobile app.

    Download the App to Unlock
    On This Page
    Macloras Tablets
    1/-
    Official PDF leaflet

    The patient information text is available above. Load the original PDF only when you need it.

    Somayeza AI
    Hello! I am your medical reading assistant. What would you like to know about this patient information leaflet?
    Successfully Stashed! 💊

    This patient information leaflet has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites